March in Review: Q1's Wake-Up Call for the Benefits Industry

The first quarter of 2026 didn't just bring us a busy news cycle—it brought a reckoning. For the past few years, the benefits industry has been able to treat certain macro challenges as "future problems." In March, those problems officially arrived on our doorstep.

 Based on the strategic planning I am doing with clients at RevGem right now, the conversation has shifted dramatically. We are no longer debating if structural changes are coming to healthcare financing, regulatory oversight, or workplace technology. We are dealing with the reality that they are already here.

 If January and February were about identifying new strategies, March was a stress test of how quickly we can deploy them. Here are the three wake-up calls that defined the end of Q1, and what they demand from leaders across the ecosystem.

1. The Coverage Floor Is Cracking—and Employers Are Holding the Ceiling

We have spent years discussing the unsustainability of employer healthcare costs, but the macro environment just poured gasoline on the fire. With the expiration of enhanced Affordable Care Act (ACA) subsidies at the end of 2025, the individual market experienced a severe shock. Recent survey data reveals that ACA premiums more than doubled for the average enrollee in 2026, leading to approximately 9% of enrollees dropping their coverage entirely.

 Simultaneously, we are watching Medicaid work requirements and funding cuts threaten to remove millions more from the public safety net. This isn't just a policy story; it is an employer story. As public coverage options shrink and become unaffordable, more individuals will inevitably turn to employer-sponsored insurance as their primary lifeline.

 The timing could not be worse. Employers are already buckling under the pressure of 6-7% projected premium increases for 2026, and Moody's recently maintained its negative outlook on the health insurance sector, citing persistently high medical loss cost inflation that continues to erase carrier margins.

 The question I am asking HR leaders and brokers is this: As the public safety net frays, employers are about to become the last line of defense for millions of Americans. Are your benefit designs prepared to absorb that structural shift, or are you still modeling renewals as if the broader market is stable?

2. The Fiduciary Reckoning Comes for Voluntary Benefits

For decades, many employers and brokers have operated under the assumption that voluntary benefits—like accident, critical illness, and hospital indemnity plans—were peripheral, low-risk offerings because they are employee-paid. This quarter, that assumption collapsed.

 A coordinated wave of ERISA class action lawsuits has placed these programs squarely in the fiduciary crosshairs. The plaintiffs are advancing a unified theory: if an employer exercises discretion over carrier selection or broker compensation within an ERISA-governed welfare plan, they are subject to ERISA’s full fiduciary framework. The complaints allege that failures in process—specifically failing to benchmark pricing or scrutinize high embedded broker commissions—caused employees to overpay for coverage.

 Crucially, these lawsuits are aggressively targeting brokers as co-fiduciaries, challenging the long-standing "mere advisor" defense. This is happening against the broader backdrop of the Consolidated Appropriations Act (CAA) of 2026, which is forcing unprecedented transparency into PBM contracts and broader healthcare fees. The regulatory and legal spotlight is shining on every dollar that moves through the benefits ecosystem.

 For CFOs and HR leaders, this is a massive wake-up call. Your voluntary benefit programs and broker compensation structures now require the exact same rigorous, documented scrutiny applied to your 401(k) plans. Transparency is no longer a nice-to-have differentiator; it is a strict legal baseline.

 The strategic imperative for brokers and advisors is clear: Can you proactively demonstrate your value, clearly articulate your commission structure, and document your selection process before a client—or a plaintiff's attorney—demands an audit?

3. The AI Trust Gap: Adoption Is High, But Anxiety Is Higher

The technology narrative in benefits has definitively moved from pilot programs to production systems. We saw this clearly in March, from Origin's $30 million raise for its AI-native global benefits platform to Collective Health expanding its partnership with Google Cloud to launch an enterprise AI platform.

 But the most important AI data point this month didn't come from a tech company; it came from the workforce. MetLife’s 2026 Employee Benefit Trends Study revealed a fascinating paradox. While 80% of employers say AI tools are now part of everyday tasks, a staggering 61% of employees remain deeply concerned about the ethical and safety risks of AI. Furthermore, nearly a quarter of employees feel they are actively competing with AI at work.

 This reveals a critical, overlooked vulnerability: the trust gap. We have spent the last two years asking if AI can be helpful. The question we need to ask now is whether our workforce actually trusts the tools we are deploying. The platforms that win in 2026 will be those that can prove their AI does not just drive administrative efficiency, but actually acts as an empathetic, transparent co-pilot that reduces employee anxiety rather than adding to it.

 Are you measuring your AI strategy by adoption rates, or are you measuring it by the trust it builds with your people?

Looking Ahead

These three forces—coverage sustainability, regulatory transparency, and the AI trust gap—are fundamentally restructuring how we do business.

 And the market is reshaping itself to meet these pressures. The consolidation we've anticipated is accelerating, evidenced most notably by Corebridge Financial and Equitable Holdings announcing a $22 billion merger to create a retirement and wealth giant. At the same time, state-level policy is moving fast to create tax incentives for ICHRA adoption, turning the individual market from a strategic alternative into a policy-driven inevitability.

 Q1 is over, and the grace period for adapting to these shifts is gone. The organizations that thrive in Q2 and beyond will be those that stop reacting to the symptoms and start solving for the structural changes underneath them.

At RevGem, this is what we work on every day. Is your strategy built for the realities of the market we are in right now?